FEM1C

Chr 5

fem-1 homolog C

Also known as: EUROIMAGE686608, EUROIMAGE783647, FEM1A

Enables ubiquitin-like ligase-substrate adaptor activity. Involved in ubiquitin-dependent protein catabolic process via the C-end degron rule pathway. Located in nucleoplasm. Part of Cul2-RING ubiquitin ligase complex. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…

Clinical highlights

Gene-disease validity (ClinGen)
neurodevelopmental disorder · ADLimitednot for standalone diagnostic reporting
Interpreting a novel variant
A dominant-negative effect is the curated mechanism (Gene2Phenotype), so a variant that simply removes the protein may not be the pathogenic class here — missense variants in functional domains often carry more weight.Curated gene-level mechanism — a prior for triage, not a per-variant call.
0
Active trials
3
Pubs (1 yr)
P/LP submissions
P/LP missense
0.48
LOEUF
DN
Mechanism· G2P

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.48LOEUF
pLI 0.629
Z-score 3.04
OE 0.19 (0.080.48)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
2.43Z-score
OE missense 0.63 (0.560.70)
212 obs / 337.7 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.19 (0.080.48)
00.351.4
Missense OE?0.63 (0.560.70)
00.61.4
Synonymous OE?0.95
01.21.6
LoF obs/exp: 3 / 16.2Missense obs/exp: 212 / 337.7Syn Z: 0.40

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

FEM1C · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →